Roxana S. Dronca
Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Roxana S. Dronca as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:33 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07285044 · The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasMayo Clinic · recruiting · Amyloidosis, Basal Cell Carcinoma, Biliary Tract Carcinoma · principal investigator
- Ph2NCT07073794 · Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate CancerMayo Clinic · recruiting · Biochemically Recurrent Prostate Carcinoma, Locally Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma · principal investigator
- N/ANCT06470750 · Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)Mayo Clinic · completed · Prostate Adenocarcinoma · principal investigator
- Ph2NCT06265285 · Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramMayo Clinic · recruiting · Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 · principal investigator
- Ph2NCT05969860 · At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced CancerMayo Clinic · recruiting · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, Advanced Bladder Carcinoma · principal investigator
- Ph1NCT03865212 · Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV MelanomaMayo Clinic · terminated · Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Choroid Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Role of Bim and soluble B7-H1 in monitoring T cell responses to anti-PD-1 therapy in melanomaR21CA197878 · NCI · MAYO CLINIC ROCHESTER · fiscal years 2015 to 2016 · $169,555 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.